Clinical Trials Logo

Metabolic Diseases clinical trials

View clinical trials related to Metabolic Diseases.

Filter by:

NCT ID: NCT05352789 Completed - Clinical trials for Stem Cell Transplant Complications

Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.

Start date: August 1, 2020
Phase:
Study type: Observational

To explore current practices of nutrition and metabolic screening, assessment and management prior to Haematopoietic Stem Cell Transplant (HSCT) in UK and ROI transplant centres. Nutrition and metabolic parameters assessed in the survey include glycaemic control, lipid function, liver function, nutritional screening, nutritional assessment, nutrition intervention (tube feeding, diet, micronutrient) and exercise. This work will be used to inform the design of a UK dual centre feasibility study of personalised nutrition and metabolic care for HSCT patients prior to transplantation.

NCT ID: NCT05348694 Active, not recruiting - Clinical trials for Glucose Metabolism Disorders

OsteoPreP: Food Supplements for Postmenopausal Bone Health

OsteoPreP
Start date: May 1, 2022
Phase: Phase 4
Study type: Interventional

To evaluate the effect of 12 months of supplementation with a probiotic (probiotic plus prebiotic; 2 capsules per day) on relative change (%) in total volumetric bone density (measured using high resolution peripheral quantitative computed tomography [HR-pQCT]) of the distal tibia.

NCT ID: NCT05348304 Completed - Metabolism Disorder Clinical Trials

Hypoglycemic Effects of a Dietary Supplement With Inositols, Gymnema Silvestre, Alpha-lactalbumin and Zinc.

EUDIA_22
Start date: June 28, 2022
Phase: N/A
Study type: Interventional

This study is aimed at evaluating the hypoglycemic effects of a dietary supplement that associates the properties of two inositols (myo-inositol and D-chiro-inositol) in the ratio 40:1 to Gymnema sylvestre, alpha-lactalbumin and zinc.

NCT ID: NCT05334342 Recruiting - Clinical trials for Spinal Cord Injuries

Low-GI Diet vs High-GI Diet in Individuals With SCI

Start date: May 5, 2022
Phase: N/A
Study type: Interventional

The purpose of this pilot research project is to examine the impact of a low-glycemic index (GI) diet on postprandial hypotension and glucose control in individuals with chronic spinal cord injury. The objectives are: 1) To evaluate the effect of the low-GI diet on the magnitude of postprandial systolic blood pressure drop compared to a high-GI control diet. 2)To evaluate the effect of a low-GI diet on postprandial glucose and insulin responses compared to a high-GI control diet.

NCT ID: NCT05321914 Recruiting - Metabolic Disease Clinical Trials

Resistance Exercise, Metabolism and Time of Day

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The aim of the current study is to determine the effect of time of day on the muscle and metabolic responses to resistance exercises in obese or overweight adults. To achieve this aim we have the following objectives: 1. Compare the effects of resistance exercise training performed in the morning vs the evening on insulin sensitivity 2. Compare the effects of resistance exercise training performed in the morning vs the evening on gains in muscle mass and strength 3. Compare the acute glucose responses to resistance exercise performed in the morning vs the evening

NCT ID: NCT05318196 Recruiting - Cancer Clinical Trials

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

NEPHROGENE2
Start date: September 5, 2022
Phase:
Study type: Observational

Managing patients with renal failure requires an understanding of the molecular mechanisms that lead to its occurrence (i.e. upstream of the disease), its worsening and its persistence (i.e. downstream), while also specifying the risk of worsening renal failure (risk stratification, intolerance to the treatment or complications (infectious, metabolic, cardiovascular, cancer…). Nephrogene 2.0 aims to study these different components of kidney, immune and solid organ transplantation (SOT)-related diseases.

NCT ID: NCT05315895 Recruiting - Cancer Clinical Trials

The Dampness Syndrome of Chinese Medicine Cohort Study

DACOS
Start date: June 6, 2022
Phase:
Study type: Observational [Patient Registry]

The researchers plain to build a large-scale, longitudinal, prospective cohort characterized by TCM dampness syndrome. With the biobank of this cohort the investigators want to find the causality between TCM dampness syndrome and clinical chronic diseases and a new way to treat clinical disease.

NCT ID: NCT05307172 Not yet recruiting - Obesity Clinical Trials

Precision Medicine Approach to Unravel the Risk Factors for Renal, Cardiovascular, Ophthalmologic, Neurologic and Hepatic Complications of Metabolic Disorders

PRECIMETAB
Start date: May 3, 2022
Phase:
Study type: Observational

There is currently no way to predict the progression of chronic kidney disease in patients with metabolic disease(s). Furthermore, the mechanisms responsible for the development and/or progression of complications remain largely unknown. In order to identify the predictive factors and/or mechanisms involved in the different complications of these diseases, we propose an approach coupling : - a classical phenotypic characterization (clinical, biological, imaging) of the patients - high-throughput screening of the genome, transcriptome, metabolome, proteome, and immunophenotyping. According to our hypothesis, this approach should allow : - Early detection of complications - Classification of patients in homogeneous groups of patients with identical evolution - Identification of the molecular mechanisms involved.

NCT ID: NCT05305287 Recruiting - Type 2 Diabetes Clinical Trials

Quantifying Hepatic Mitochondrial Fluxes in Humans

Start date: November 1, 2022
Phase: Phase 4
Study type: Interventional

In this study the investigators will quantitate hepatic mitochondrial fluxes in T2D patients with NAFL and NASH before and after 16-weeks treatment with the insulin sensitizer pioglitazone

NCT ID: NCT05284162 Recruiting - Clinical trials for Cardiovascular Diseases

Health Coaching Programme on Health Promoting Behaviours in Middle-Aged Adults With Cardiometabolic Risk

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Cardiometabolic disease has been an increasing trend globally and remains the major cause of morbidity and mortality in Hong Kong. Health coaching intervention are generally effective for managing chronic disease and prevention of complication. However, there is fewer attention on the effects of health coaching in primary disease prevention. This study aims to evaluate the effects of health coaching programme on increasing health promoting behaviours in middle-aged adults with cardiometabolic risk.